Essay: Drugmakers are applying the mRNA technology behind Covid-19 vaccines to other diseases. Can the new therapies help to cure the flu, cancer and HIV?
The vaccines that have helped billions of people around the world to protect themselves from Covid-19 were a surprise even to their manufacturers. Harnessing a new and relatively untried technology called messenger RNA, or mRNA, the vaccines were available many months and possibly even years ahead of when health experts expected safe and effective traditional vaccines to arrive.
Now scientists, governments and drugmakers are asking, what else can mRNA do? Many believe that mRNA could serve as the basis for a new generation of vaccines and drugs against a range of other diseases. Efforts in development include cancer therapies tailored to individual patients that can be assembled in a few weeks and HIV vaccines to be given periodically in lieu of current daily pills.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
The COVID Vaccine Doesn't Affect Fertility, but COVID Itself DoesCOVID-19 temporarily reduces male fertility by 18%, but the vaccine has no lasting effect on fertility in men or women, a study found.
Lire la suite »
People With HIV Less Likely To Be Vaccinated Against Covid-19, CDC FindsSome experts fear Covid infections in people with untreated HIV could cause mutations that lead to novel variants.
Lire la suite »
NYC school attendance stabilizes as COVID-19 wave recedesPlagued by skyrocketing COVID-19 infections in schools after the winter break, the DOE saw hundreds of thousands of kids missing from their buildings each day.
Lire la suite »
Utah reports about 3,500 new COVID-19 cases as hospitalizations riseUtah reported 3,482 new COVID-19 cases on Thursday — far higher than most days throughout the pandemic, but further evidence that a January surge of infections fueled by the highly contagious omicron variant may be winding down.
Lire la suite »
Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipientsVaccines produce robust Tcell immunity against SARSCoV2 variants. Neutralizing antibodies were lowest against Omicron but can be partially restored with booster vaccination. SciImmunology
Lire la suite »
‘Ghosts’ Lifts Lionsgate Revenues, But COVID Production Delays Hurt EarningsA few breakout television hits lifted quarterly revenues at Lionsgate, but production delays related to COVID-19 and sluggish subscriber growth at the company’s Starz pay television and strea…
Lire la suite »